1,684
Views
7
CrossRef citations to date
0
Altmetric
Review

What is the evidence for managing tone in young children with, or at risk of developing, cerebral palsy: a systematic review

, , , &
Pages 619-630 | Received 13 Jul 2015, Accepted 08 Feb 2016, Published online: 30 Mar 2016

References

  • Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol. 2007;109:8–14.
  • Smithers‐Sheedy H, Badawi N, Blair E, et al. What constitutes cerebral palsy in the twenty‐first century? Dev Med Child Neurol. 2014;56:323–328.
  • Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005;47:571–576.
  • Tosi LL, Maher N, Moore DW, et al. Adults with cerebral palsy: a workshop to define the challenges of treating and preventing secondary musculoskeletal and neuromuscular complications in this rapidly growing population. Dev Med Child Neurol. 2009;51:2–11.
  • Vargus-Adams J. Understanding function and other outcomes in cerebral palsy. Phys Med Rehabil Clin North Am. 2009;20:567–575.
  • Sanger TD, Delgado MR, Gaebler-Spira D, et al. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 2003;111:e89–e97.
  • Hägglund G, Wagner P. Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet Disord. 2008;9:150.
  • Østensjø S, Carlberg EB, Vøllestad NK. Motor impairments in young children with cerebral palsy: relationship to gross motor function and everyday activities. Dev Med Child Neurol. 2004;46:580–589.
  • Scholtes VA, Becher JG, Beelen A, et al. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol. 2006;48:64–73.
  • Howard J, Soo B, Graham HK, et al. Cerebral palsy in Victoria: motor types, topography and gross motor function. J Paediatr Child Health. 2005;41:479–483.
  • Krigger KW. Cerebral palsy: an overview. Am Fam Physician. 2006;73:91–100.
  • Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206–207.
  • Haugh A, Pandyan A, Johnson G. A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil. 2006;28:899–907.
  • Flamand VH, Massé-Alarie H, Schneider C. Psychometric evidence of spasticity measurement tools in cerebral palsy children and adolescents: a systematic review. J Rehabil Med. 2013;45:14–23.
  • Himmelmann K, McManus V, Hagberg G, et al. Dyskinetic cerebral palsy in Europe: trends in prevalence and severity. Arch Dis Childh. 2009;94:921–926.
  • Reid SM, Carlin JB, Reddihough DS. Distribution of motor types in cerebral palsy: how do registry data compare? Dev Med Child Neurol. 2011;53:233–238.
  • Krägeloh-Mann I, Cans C. Cerebral palsy update. Brain Dev. 2009;31:537–544.
  • Monbaliu E, Ortibus E, De Cat J, et al. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy. Dev Med Child Neurol. 2012;54:278–283.
  • Barry MJ, Van Swearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. – Dev Med Child Neurol. 1999;41:404–411.
  • Battini R, Sgandurra G, Petacchi E, et al. Movement disorder-childhood rating scale: reliability and validity. Pediatr Neurol. 2008;39:259–265.
  • Beckung E, Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol. 2002;44:309–316.
  • Krägeloh-Mann I, Horber V. The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol. 2007;49:144–151.
  • McConachie H, Colver A, Forsyth R, et al. Participation of disabled children: how should it be characterised and measured? Disabil Rehabil. 2006;28:1157–1164.
  • Palisano RJ, Kang LJ, Chiarello LA, et al. Social and community participation of children and youth with cerebral palsy is associated with age and gross motor function classification. Phys Ther. 2009;89:1304–1314.
  • Rauch A, Cieza A, Stucki G. How to apply the International classification of functioning, disability and health (ICF) for rehabilitation management in clinical practice. Eur J Phys Rehabil Med. 2008;44:329–342.
  • Chiarello LA, Palisano RJ, Maggs JM, et al. Family priorities for activity and participation of children and youth with cerebral palsy. Phys Ther. 2010;90:1254–1264.
  • Ramstad K, Jahnsen R, Skjeldal OH, et al. Parent‐reported participation in children with cerebral palsy: the contribution of recurrent musculoskeletal pain and child mental health problems. Dev Med Child Neurol. 2012;54:829–835.
  • Flett PJ. Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health. 2003;39:6–14.
  • Gormley ME Jr. Treatment of neuromuscular and musculoskeletal problems in cerebral palsy. Pediatr Rehabil. 2001;4:5–16.
  • Hadden KL, von Baeyer CL. Pain in children with cerebral palsy: common triggers and expressive behaviors. Pain. 2002;99:281–288.
  • Novak I, Hines M, Goldsmith S, et al. Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics. 2012;130:e1285–e1312.
  • McDougall J, Wright V. The ICF-CY and Goal Attainment Scaling: benefits of their combined use for pediatric practice. Disabil Rehabil. 2009;31:1362–1372.
  • Rosenbaum P, Gorter J. The ‘F‐Words’ in childhood disability: i swear this is how we should think! Child Care Health Dev. 2012;38:457–463.
  • World Health Organization. International Classification of Functioning, Disability, and Health: Children & Youth Version: ICF-CY. Geneva: World Health Organization; 2007.
  • Delgado MR, Hirtz D, Aisen M, et al. Practice Parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010;74:336–343.
  • Grunt S, Becher JG, Vermeulen RJ. Long-term outcome and adverse effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2011;53:490–498.
  • Duquette SA, Guiliano AM, Starmer DJ. Whole body vibration and cerebral palsy: a systematic review. J Can Chiropr Assoc. 2015;59:245.
  • Pin T, Dyke P, Chan M. The effectiveness of passive stretching in children with cerebral palsy. Dev Med Child Neurol. 2006;48:855–862.
  • Cheng HY, Ju YY, Chen CL, et al. Managing spastic hypertonia in children with cerebral palsy via repetitive passive knee movements. J Rehabil Med. 2012;235–240.
  • Novak I, Mcintyre S, Morgan C, et al. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013;55:885–910.
  • Aisen ML, Kerkovich D, Mast J, et al. Cerebral palsy: clinical care and neurological rehabilitation. Lancet Neurol. 2011;10:844–852.
  • Garvey MA, Giannetti ML, Alter KE, et al. Cerebral palsy: new approaches to therapy. Curr Neurol Neurosci Rep. 2007;7:147–155.
  • Vanderveen J, Bassler D, Robertson C, et al. Early interventions involving parents to improve neurodevelopmental outcomes of premature infants: a meta-analysis. J Perinatol. 2009;29:343–351.
  • Sukal-Moulton T, Krosschell KJ, Gaebler-Spira DJ, et al. Motor impairment factors related to brain injury timing in early hemiparesis, Part I expression of upper-extremity weakness. Neurorehabil Neural Repair. 2014;28:13–23.
  • Hadders-Algra M. Early diagnosis and early intervention in cerebral palsy. Front Neurol. 2014;5:185. doi: 10.3389/fneur.2014.00185.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341. doi:10.3389/fneur.2014.00185.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
  • Evans D. Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. J Clin Nurs. 2003;12:77–84.
  • Grossman J, Mackenzie FJ. The randomized controlled trial: gold standard, or merely standard? Perspect Biol Med. 2005;48:516–534.
  • Blair E. Discussion: gold is not always good enough: the shortcomings of randomization when evaluating interventions in small heterogeneous samples. J Clin Epidemiol. 2004;57:1219–1222.
  • GRADE Working Group. Grading quality of evidence and strength of recommendations. Br Med J. 2004;328:1490.
  • Robey RR, Schultz MC, Crawford AB, et al. Review: Single-subject clinical-outcome research: designs, data, effect sizes, and analyses. Aphasiology. 1999;13:445–473.
  • Love S, Novak I, Kentish M, et al. Botulinum toxin assessment, intervention and after‐care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol. 2010;17:9–37.
  • Pandyan A, Johnson G, Price C, et al. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999;13:373–383.
  • Higgins JP, Green S. (2008). Cochrane handbook for systematic reviews of interventions. Volume 5. Chichester: Wiley-Blackwell.
  • Akbari A, Javad zadeh M, Shahraki S, et al. The effects of functional therapy on motor development in children with cerebral palsy. Iran J Child Neurol. 2009;3:23–32.
  • Batra M, Sharma VP, Batra V, et al. Neurofacilitation of developmental reaction (NFDR) approach: a practice framework for integration/modification of early motor behavior (primitive reflexes) in cerebral palsy. Indian J Pediatr. 2012;79:659–663.
  • Park ES, Park CI, Kim DY, et al. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection. Arch Phys Med Rehabil. 2002;83:1592–1596.
  • Schulz E, Mathew OP. Is oral baclofen effective in neonatal hypertonia? J Child Neurol. 2012;27:197–199.
  • Tedroff K, Lowing K, Haglund AY, et al. Botulinum toxin A treatment in toddlers with cerebral palsy. Acta Paediatr. Int J Paediatr. 2010;99:1156–1162.
  • Sherrington C, Moseley AM, Herbert RD, et al. Ten years of evidence to guide physiotherapy interventions: Physiotherapy Evidence Database (PEDro). Br J Sports Med. 2009;44:836–837.
  • Kmet LM, Lee RC, Cook LS. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Canada: Alberta Heritage Foundation for Medical Research; 2004.
  • Centre of Evidence-Based Physiotherapy (CEBP) 1999. PEDro scale. In The George Institute for Global Health, University of Sydney; [cited 2012 Feb 14]. Available from: http://www.pedro.org.au/wp-content/uploads/PEDro_scale.pdf.
  • Lee L, Packer TL, Tang SH, et al. Self-management education programs for age-related macular degeneration: a systematic review. Aust J Ageing. 2008;27:170–176.
  • Phillips B, Ball C, Sackett D, et al. (1998). Oxford Centre for Evidence-based Medicine-levels of evidence (March 2009). Centre for Evidence Based Medicine Web site. Available from: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
  • Palmer FB. Strategies for the early diagnosis of cerebral palsy. J Pediatr. 2004;145:S8–S11.
  • Hedström L, Brogren Carlberg E. Missing data in physiotherapists’ assessments of children with cerebral palsy. Eur J Physiother. 2015;17:66–73.
  • Gorter JW, Verschuren O, van Riel L, et al. The relationship between spasticity in young children (18 months of age) with cerebral palsy and their gross motor function development. BMC Musculoskelet Disord. 2009;10:108.
  • Pascual-Pascual SI, Pascual-Castroviejo I. Safety of botulinum toxin type A in children younger than 2 years. Eur J Paediatr Neurol. 2009;13:511–515.
  • Naumann M, Albanese A, Heinen F, et al. Safety and efficacy of botulinum toxin type A following long‐term use. Eur J Neurol. 2006;13:35–40.
  • Majnemer A, Mazer B. New directions in the outcome evaluation of children with cerebral palsy. Semin Pediatr Neurol. 2004;11:11–17.
  • Rozkalne Z, Bertule D. (2014). Measurement of activities and participation for children with cerebral palsy: a systematic review. In SHS Web of Conferences. Vol. 10. Les Ulis: EDP Sciences, p. 00038.
  • Wright F, Rosenbaum PL, Goldsmith CH, et al. How do changes in body functions and structures, activity, and participation relate in children with cerebral palsy? Dev Med Child Neurol. 2008;50:283–289.
  • Johnson GR. Outcome measures of spasticity. Eur J Neurol. 2002;9:10–16.
  • dos Santos AN, Pavão SL, de Campos AC, et al. International classification of functioning, disability and health in children with cerebral palsy. Disabil Rehabil. 2012;34:1053–1058.
  • Debuse D, Brace H Outcome measures of activity for children with cerebral palsy: a systematic review. Pediatr Phys Ther. 2011;23:221–231.
  • Russell DJ, Rosenbaum PL, Avery LM, et al. (2002). Gross motor function measure (GMFM-66 and GMFM-88) user's manual. Cambridge: Cambridge University Press.
  • Haley SM. (1992). Pediatric Evaluation of Disability Inventory (PEDI): development, standardization and administration manual. Boston: PEDI Research Group.
  • Morgan C, Novak I, Badawi N. Enriched environments and motor outcomes in cerebral palsy: systematic review and meta-analysis. Pediatrics 2013;132:e735–e746.
  • Ohgi S, Fukuda M, Akiyama T, et al. Effect of an early intervention programme on low birthweight infants with cerebral injuries. J Paediatr Child Health. 2004;40:689–695.
  • Raina P, O'Donnell M, Rosenbaum P, et al. The health and well-being of caregivers of children with cerebral palsy. Pediatrics. 2005;115:e626–e636.
  • Yang JF, Livingstone D, Brunton K, et al. Training to enhance walking in children with cerebral palsy: are we missing the window of opportunity? Semin Pediatr Neurol. 2013;20:106–115.
  • Darsaklis V, Snider LM, Majnemer A, et al. Predictive validity of Prechtl’s method on the qualitative assessment of general movements: a systematic review of the evidence. Dev Med Child Neurol. 2011;53:896–906.
  • Sackett DL, Straus SE, Richardson WS, et al. Evidence based medicine: how to practice and teach EBM. 2nd ed. Edinburgh: Churchill Livingstone; 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.